HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

cyclic citrullinated peptide

a synthetic peptide that functions as a target for autoantibodies with a very high specificity for rheumatoid arthritis
Also Known As:
CCP peptide
Networked: 642 relevant articles (13 outcomes, 77 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Deane, Kevin D: 10 articles (01/2021 - 01/2005)
2. Gregersen, Peter K: 9 articles (01/2021 - 12/2005)
3. Holers, V Michael: 9 articles (01/2021 - 01/2005)
4. Mikuls, Ted R: 9 articles (01/2021 - 09/2006)
5. Trouw, Leendert A: 8 articles (01/2021 - 01/2011)
6. Karlson, Elizabeth W: 7 articles (12/2019 - 06/2007)
7. Moreland, Larry W: 7 articles (07/2017 - 09/2006)
8. Huizinga, Tom W J: 7 articles (04/2013 - 01/2005)
9. Emery, Paul: 6 articles (01/2021 - 09/2009)
10. Robinson, William H: 6 articles (01/2021 - 07/2013)

Related Diseases

1. Rheumatoid Arthritis
2. Arthritis (Polyarthritis)
3. Pain (Aches)
12/01/2023 - "Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis."
04/01/2022 - "A significantly high correlation between Modified Health Assessment Questionnaire and disease activity score-28 was noted along with pain, tenderness, swollen joints, patient global assessment, age and erythrocyte sedimentation rate (p<0.05), while poor correlation was found with gender, disease duration, rheumatoid arthritis factor and anti-cyclic citrullinated peptide antibody (p>0.05). "
02/01/2002 - "The developed prediction model consisted of 7 variables: symptom duration at first visit, morning stiffness for > or =1 hour, arthritis in > or =3 joints, bilateral compression pain in the metatarsophalangeal joints, rheumatoid factor positivity, anti-cyclic citrullinated peptide antibody positivity, and the presence of erosions (hands/feet). "
01/01/2007 - "However, no differences were found between the groups of patients with PsA in terms of seropositivity for rheumatoid factor and antibodies to cyclic citrullinated peptide, enthesitis, and spinal pain and stiffness. "
01/01/2006 - "Clinical indicators of persistence include symptom duration at first visit, early morning stiffness for > 1 h, arthritis in more than three joints, bilateral compression pain in metatarsophalangeal joints, rheumatoid factor positivity, anti-cyclic citrullinated peptide antibody positivity, erosions on hand or feet X-rays and a family history of rheumatoid arthritis. "
4. Chronic Obstructive Pulmonary Disease (COPD)
5. Lung Diseases (Lung Disease)

Related Drugs and Biologics

1. Rheumatoid Factor
2. Anti-Citrullinated Protein Antibodies
3. Antibodies
4. Immunoglobulin M (IgM)
5. Vimentin
6. Immunoglobulin G (IgG)
7. Immunoglobulin A (IgA)
8. Immunosorbents
9. Enzymes
10. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

Related Therapies and Procedures

1. Therapeutics
2. Biological Therapy
3. Hormone Replacement Therapy (Therapy, Hormone Replacement)
4. Home Parenteral Nutrition
5. Splenectomy